
Erudition Therapeutics Private Limited
About Erudition Therapeutics Private Limited
Data last updated:
Erudition Therapeutics Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 04 June 2024.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U21000RJ2024PTC095003.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors including Swapnil Sharma and Vartika Paliwal.
Its last annual general meeting (AGM) was held on 30 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Jaipur, Rajasthan.
As per the financials filed for FY 2026, the company reported a revenue of ₹2.04 Lakh, a decline of 19% compared to the previous year. For the same year it recorded EBITDA of ₹60 (EBITDA margin 0%).
Company details
Contact details
Erudition Therapeutics Private Limited's registered office is in Jaipur, Rajasthan.
- Registered AddressEf 085 Gulmohar Garden, Manpura Vatika Road, Jaipur, Rajasthan, India – 302019
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Erudition Therapeutics is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Erudition Therapeutics Private Limited, buy the company report.
Financials of Erudition Therapeutics Private Limited
FY 2026 filings availableErudition Therapeutics Private Limited reported revenue of ₹2.04 Lakh (down 19% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year. EBITDA fell 84% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹2.04 Lakh | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹60 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0% | |
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Erudition Therapeutics Private Limited, buy the company report.
Board of directors of Erudition Therapeutics Private Limited
Erudition Therapeutics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnil Sharma | Director | 04 Jun 2024 | 2 Years 5 Months | Current |
| Vartika Paliwal | Director | 04 Jun 2024 | 2 Years 5 Months | Current |
| Sarvesh Kumar Paliwal | Director | 04 Jun 2024 | 2 Years 5 Months | Current |
Auditor
Erudition Therapeutics Private Limited is audited by G.K.MITTAL & ASSOCIATES for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.K.MITTAL & ASSOCIATES | FY 2026 | 005842C |
Shareholding
The shareholding of Erudition Therapeutics Private Limited is on record for 2 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Erudition Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Erudition Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Erudition Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Erudition Therapeutics Private Limited has 1 active EPFO establishment as of Nov 13, 2026.
GST
No GST registration is on our record for Erudition Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Erudition Therapeutics Private Limited has 3 board changes on record since 2024: 3 appointments. The latest: Sarvesh Kumar Paliwal was appointed as Director on 04 Jun 2024.
Frequently asked questions
Erudition Therapeutics is an active private limited company based in Jaipur, Rajasthan, India. The company works in paper and paper products, within the paper industry. It was incorporated on 04 June 2024 (2+ years old) and is registered under CIN U21000RJ2024PTC095003.
Erudition Therapeutics has 3 current directors:
- Swapnil Sharma - Director
- Vartika Paliwal - Director
- Sarvesh Kumar Paliwal - Director
The latest financial statements of Erudition Therapeutics on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 June 2026. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Erudition Therapeutics is U21000RJ2024PTC095003. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Erudition Therapeutics was incorporated on 04 June 2024, making it 2+ years old. It is registered with the Registrar of Companies, Jaipur.
Sarvesh Kumar Paliwal was appointed as Director on 04 Jun 2024. Swapnil Sharma was appointed as Director on 04 Jun 2024. Vartika Paliwal was appointed as Director on 04 Jun 2024.
The registered office of Erudition Therapeutics is at Ef 085 Gulmohar Garden, Manpura Vatika Road, Jaipur, Rajasthan, India – 302019.
Erudition Therapeutics operates in the paper industry, in the paper and paper products segment.
Erudition Therapeutics can be reached at its registered office: Ef 085 Gulmohar Garden, Manpura Vatika Road, Jaipur, Rajasthan, India – 302019.
Erudition Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Jaipur.

